Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

-
June 29, 2017
Oslo Cancer Cluster

International Collaboration in Cancer Innovation

24 oncology innovators from 9 international hubs attended the 6th International Cancer Cluster Showcase in San Diego.

International Collaboration in Cancer Innovation

24 oncology innovators from 9 international hubs attended the 6th International Cancer Cluster Showcase in San Diego.

The International Cancer Cluster Showcase (ICCS) was born back in 2011 in Washington DC, during the world’s largest biotech conference, BIO International Convention. International cluster managers and representatives from the oncology field in Boston, Toulouse and Oslo met during a networking reception and agreed to team up for a joint initiative to expose their emerging oncology innovators to the global oncology community gathering at BIO.

This idea matured in a stimulating and dynamic annual meeting featuring oncology innovators from several North American and European innovation hubs.

Exciting partnering opportunities
During the  6th edition of ICCS around 200 delegates learned about exciting partnering opportunities pitched by 24 companies from 9 innovation hubs.

Oslo Cancer Cluster was represented by its member companies Oncoimmunity AS and Nordic Nanovector. The two companies presented their preclinical and clinical candidates for treating hematological cancers. Inven2, Norway’ largest tech transfer organisation, gave a glimpse into their growing oncology portfolio.

An overwhelming amount of cutting edge oncology innovations from leading North American and European industry clusters were presented in compact presentations. Poster sessions, networking parts and a final reception allowed the participants to connect and discuss collaboration opportunities.

– I hope that the ICCS 2017 reception was as productive for the participating biotechs as the BIO reception in Washington 6 years ago was for the founders of ICCS, said Jutta Heix, International Advisor at Oslo Cancer Cluster and coordinator for the event.

Last updated:
June 29, 2017

Oslo Cancer Cluster

Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines. We are a national non-profit member organisation with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organisations – all working in the cancer field. They represent the entire oncology value chain, doing everything from exploratory research to selling therapeutics and diagnostics to global markets.

Click here to read more about us!
Get in touch with us!
Visit us

Oslo Cancer Cluster
Ullernchausséen 64
0379 Oslo

Send us mail

The International Cancer Cluster Showcase (ICCS) was born back in 2011 in Washington DC, during the world’s largest biotech conference, BIO International Convention. International cluster managers and representatives from the oncology field in Boston, Toulouse and Oslo met during a networking reception and agreed to team up for a joint initiative to expose their emerging oncology innovators to the global oncology community gathering at BIO.

This idea matured in a stimulating and dynamic annual meeting featuring oncology innovators from several North American and European innovation hubs.

Exciting partnering opportunities
During the  6th edition of ICCS around 200 delegates learned about exciting partnering opportunities pitched by 24 companies from 9 innovation hubs.

Oslo Cancer Cluster was represented by its member companies Oncoimmunity AS and Nordic Nanovector. The two companies presented their preclinical and clinical candidates for treating hematological cancers. Inven2, Norway’ largest tech transfer organisation, gave a glimpse into their growing oncology portfolio.

An overwhelming amount of cutting edge oncology innovations from leading North American and European industry clusters were presented in compact presentations. Poster sessions, networking parts and a final reception allowed the participants to connect and discuss collaboration opportunities.

– I hope that the ICCS 2017 reception was as productive for the participating biotechs as the BIO reception in Washington 6 years ago was for the founders of ICCS, said Jutta Heix, International Advisor at Oslo Cancer Cluster and coordinator for the event.

Last updated:
June 29, 2017

Oslo Cancer Cluster

Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines. We are a national non-profit member organisation with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organisations – all working in the cancer field. They represent the entire oncology value chain, doing everything from exploratory research to selling therapeutics and diagnostics to global markets.

Click here to read more about us!
Get in touch with us!
Visit us

Oslo Cancer Cluster
Ullernchausséen 64
0379 Oslo

Send us mail